SciClone Pharmaceuticals

OverviewSuggest Edit

SciClone Pharmaceuticals (SciClone) is a global specialty pharmaceutical company with a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders. Its proprietary lead product, ZADAXIN (thymalfasin), may be used for the treatment of hepatitis B (HBV), hepatitis C (HCV), and certain cancers, and as an immune system enhancer, according to the local regulatory approvals.

TypePrivate
Founded1989
HQFoster City, US
Websitesciclone.com

Locations

SciClone Pharmaceuticals is headquartered in
Foster City, United States

Location Map

Latest Updates

Employees (est.) (Oct 2020)84
Revenue (FY, 2016)$160.1 M(+2%)
Share Price (Oct 2017)$11.2 (+2%)
Cybersecurity ratingAMore

SciClone Pharmaceuticals Office Locations

SciClone Pharmaceuticals has an office in Foster City
Foster City, US (HQ)
950 Tower Ln #900
Show all (1)

SciClone Pharmaceuticals Financials and Metrics

Summary Metrics

Founding Date

1989
Show all financial metrics

SciClone Pharmaceuticals Revenue

SciClone Pharmaceuticals's revenue was reported to be $160.10 m in FY, 2016 which is a 1.8% increase from the previous period.
USD

Revenue (Q2, 2017)

44.5m

Net income (Q2, 2017)

12.2m

EBIT (Q2, 2017)

12.3m

Cash (30-Jun-2017)

157.3m
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

133.6m156.3m127.1m134.8m157.3m160.1m

Revenue growth, %

6%17%2%

Sales and marketing expense

48.9m70.3m55.8m48.5m54.0m54.7m

General and administrative expense

24.0m21.4m32.5m22.7m27.9m34.2m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

33.1m37.4m41.1m41.4m40.7m29.8m29.3m35.2m26.6m32.5m34.3m33.6m37.9m42.9m36.5m39.0m40.5m42.9m44.5m

Cost of goods sold

5.2m5.0m

Gross profit

27.9m32.4m

Gross profit Margin, %

84%87%
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Cash

66.7m84.2m85.8m86.2m101.4m134.4m

Accounts Receivable

42.2m38.1m40.0m40.3m39.4m

Prepaid Expenses

1.6m1.8m2.3m2.6m3.7m

Inventories

8.8m10.4m15.2m10.7m11.0m16.6m
USDQ2, 2011

Financial Leverage

1.4 x
Show all financial metrics

SciClone Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

A

90/100

SecurityScorecard logo

SciClone Pharmaceuticals Online and Social Media Presence

Embed Graph

SciClone Pharmaceuticals Frequently Asked Questions

  • When was SciClone Pharmaceuticals founded?

    SciClone Pharmaceuticals was founded in 1989.

  • How many employees does SciClone Pharmaceuticals have?

    SciClone Pharmaceuticals has 84 employees.

  • What is SciClone Pharmaceuticals revenue?

    Latest SciClone Pharmaceuticals annual revenue is $160.1 m.

  • What is SciClone Pharmaceuticals revenue per employee?

    Latest SciClone Pharmaceuticals revenue per employee is $1.9 m.

  • Who are SciClone Pharmaceuticals competitors?

    Competitors of SciClone Pharmaceuticals include Roivant Sciences, AZTherapies and Sol-Gel Technologies.

  • Where is SciClone Pharmaceuticals headquarters?

    SciClone Pharmaceuticals headquarters is located at 950 Tower Ln #900, Foster City.

  • Where are SciClone Pharmaceuticals offices?

    SciClone Pharmaceuticals has an office in Foster City.

  • How many offices does SciClone Pharmaceuticals have?

    SciClone Pharmaceuticals has 1 office.